Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Thejew on Jun 09, 2020 9:53pm
408 Views
Post# 31131521

Underwriters know something big is coming.

Underwriters know something big is coming. As frustrated as I am and as shady as this looks right now, there is no way the underwriters would put up 25M of their own money if they did not know something big was on the horizon. 

I'm taking deep breaths and convincing myself to not sell tomorrow out of frustration and actually buy more on the dip. 

Underwriters are only receiving a 10% discount, not much at all. They could easily lose money on this....but they won't. They know something is coming that will make them much more than 10% and something big enough to pop 50% back to .60 (if not way higher) so they can excersize their options. 

I know this is so hard to comprehend right now and the insider selling throws a huge monkey wrench in the program and thought process of what the F is going on, but this is actually a very bullish deal. 

IMHO. 


Bullboard Posts